UBS Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Sell |
391,221
-25,789
| -6% | -$2.74M | 0.01% | 1339 |
|
|
2025
Q1 | $51.8M | Buy |
417,010
+86,167
| +26% | +$10.7M | 0.01% | 1145 |
|
|
2024
Q4 | $40.7M | Buy |
330,843
+167,105
| +102% | +$20.6M | 0.01% | 1237 |
|
|
2024
Q3 | $18.2M | Buy |
163,738
+30,949
| +23% | +$3.45M | ﹤0.01% | 1335 |
|
|
2024
Q2 | $14.2M | Sell |
132,789
-31,611
| -19% | -$3.37M | ﹤0.01% | 1418 |
|
|
2024
Q1 | $19.8M | Sell |
164,400
-8,547
| -5% | -$1.03M | ﹤0.01% | 1201 |
|
|
2023
Q4 | $21.3M | Buy |
172,947
+26,844
| +18% | +$3.3M | 0.01% | 1072 |
|
|
2023
Q3 | $18.9M | Sell |
146,103
-13,622
| -9% | -$1.76M | 0.01% | 1068 |
|
|
2023
Q2 | $19.8M | Sell |
159,725
-13,972
| -8% | -$1.73M | 0.01% | 1060 |
|
|
2023
Q1 | $25.4M | Sell |
173,697
-71,066
| -29% | -$10.4M | 0.01% | 883 |
|
|
2022
Q4 | $39M | Buy |
244,763
+84,347
| +53% | +$13.4M | 0.01% | 685 |
|
|
2022
Q3 | $21.4M | Buy |
160,416
+6,540
| +4% | +$872K | 0.01% | 882 |
|
|
2022
Q2 | $24M | Sell |
153,876
-15,198
| -9% | -$2.37M | 0.01% | 884 |
|
|
2022
Q1 | $26.3M | Sell |
169,074
-14,173
| -8% | -$2.21M | 0.01% | 915 |
|
|
2021
Q4 | $23.3M | Sell |
183,247
-3,307
| -2% | -$421K | 0.01% | 1047 |
|
|
2021
Q3 | $24.3M | Buy |
186,554
+9,102
| +5% | +$1.19M | 0.01% | 1006 |
|
|
2021
Q2 | $31.5M | Buy |
177,452
+45,453
| +34% | +$8.07M | 0.01% | 856 |
|
|
2021
Q1 | $21.7M | Sell |
131,999
-35,925
| -21% | -$5.9M | 0.01% | 1030 |
|
|
2020
Q4 | $27.7M | Sell |
167,924
-70,255
| -29% | -$11.6M | 0.01% | 856 |
|
|
2020
Q3 | $34M | Sell |
238,179
-11,756
| -5% | -$1.68M | 0.01% | 672 |
|
|
2020
Q2 | $27.6M | Sell |
249,935
-41,680
| -14% | -$4.6M | 0.01% | 710 |
|
|
2020
Q1 | $29.1M | Buy |
291,615
+23,157
| +9% | +$2.31M | 0.01% | 620 |
|
|
2019
Q4 | $40.1M | Sell |
268,458
-167,067
| -38% | -$24.9M | 0.01% | 690 |
|
|
2019
Q3 | $55.8M | Buy |
435,525
+6,323
| +1% | +$810K | 0.02% | 516 |
|
|
2019
Q2 | $61.2M | Sell |
429,202
-80,094
| -16% | -$11.4M | 0.02% | 474 |
|
|
2019
Q1 | $72.8M | Buy |
509,296
+119,928
| +31% | +$17.1M | 0.03% | 397 |
|
|
2018
Q4 | $48.3M | Sell |
389,368
-56,114
| -13% | -$6.96M | 0.02% | 476 |
|
|
2018
Q3 | $74.9M | Buy |
445,482
+42,132
| +10% | +$7.08M | 0.03% | 395 |
|
|
2018
Q2 | $69.5M | Buy |
403,350
+23,550
| +6% | +$4.06M | 0.03% | 407 |
|
|
2018
Q1 | $57.3M | Buy |
379,800
+10,256
| +3% | +$1.55M | 0.02% | 452 |
|
|
2017
Q4 | $49.8M | Buy |
369,544
+69,097
| +23% | +$9.3M | 0.02% | 510 |
|
|
2017
Q3 | $43.9M | Sell |
300,447
-13,185
| -4% | -$1.93M | 0.02% | 509 |
|
|
2017
Q2 | $48.8M | Sell |
313,632
-24,801
| -7% | -$3.86M | 0.03% | 446 |
|
|
2017
Q1 | $49.1M | Buy |
338,433
+52,532
| +18% | +$7.62M | 0.03% | 442 |
|
|
2016
Q4 | $31.2M | Buy |
285,901
+68,268
| +31% | +$7.44M | 0.02% | 569 |
|
|
2016
Q3 | $26.4M | Buy |
217,633
+17,676
| +9% | +$2.15M | 0.02% | 620 |
|
|
2016
Q2 | $28.3M | Buy |
199,957
+52,594
| +36% | +$7.43M | 0.02% | 570 |
|
|
2016
Q1 | $19.2M | Sell |
147,363
-11,325
| -7% | -$1.48M | 0.01% | 710 |
|
|
2015
Q4 | $22.3M | Sell |
158,688
-24,727
| -13% | -$3.48M | 0.01% | 690 |
|
|
2015
Q3 | $24.4M | Buy |
183,415
+29,133
| +19% | +$3.87M | 0.02% | 603 |
|
|
2015
Q2 | $27.2M | Buy |
154,282
+30,766
| +25% | +$5.42M | 0.02% | 617 |
|
|
2015
Q1 | $21.3M | Sell |
123,516
-42,042
| -25% | -$7.26M | 0.01% | 737 |
|
|
2014
Q4 | $27.1M | Buy |
+165,558
| New | +$27.1M | 0.02% | 650 |
|